Post stroke depression

Hospital Medicine

Volumn 62, Issue 5, 2001, Pages 268-273

  Gall, Angela ^a  

^a WOODEND HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTIDEPRESSANT AGENT;

CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; COGNITIVE THERAPY; COMMUNICATION DISORDER; DEPRESSION; DIFFERENTIAL DIAGNOSIS; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; METABOLISM; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; REMISSION; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CEREBROVASCULAR ACCIDENT; COGNITIVE THERAPY; COMMUNICATION BARRIERS; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; PSYCHOLOGICAL TESTS; REMISSION, SPONTANEOUS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0035347553     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2001.62.5.1568     Document Type: Article

References (46)

1. Abiodun OA (1994) A validity study of the hospital anxiety and depression scale in general hospital units and a community hospital sample in Nigeria. Br J Psychiatry 165: 669-72
2. Andersen G (1995) Treatment of uncontrolled crying after stroke. Drugs and Aging 16: 105-11
3. Andersen ü, Vestergaard K, Lauritzen L (1994) Effective treatment of post stroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25: 1099-104
4. Astrom M, Adolfson R. Asplund K (1993) Major depression in stroke patients. Streike 24: 976-82
5. Beck AT. Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psvchiatn- 4: 53-63
6. Bridges KW, Goldberg DP (1986) The validation of the GHQ-28 and the use of the MMSE in neurological in patients. Br J Psvchiatry 148: 548-53
7. Brown KW. Sloan RL. Pentland B (1998) Fluoxetine as a treatment for post-stroke emotionalism. Ada Psvchiat Sum;/6: 455-8
8. Bryer .IP, Starksein SE, Votypka V. Parikh RM, Price TR. Robinson RG (1992) Reduction of CSF monoamine metabolites in post stroke depression: a preliminary report. J Neumpsych Clin Neuroxci 4: 440-2
9. Burvill JG, Anderson CS, Jamrozik K, Stewart-Wynne EG. Chakera TMH (1995) Screening instruments for depression and anxiety following stroke: experience in the Perth community stroke study. Acta Psvchiat Scand 91: 252-7
10. Clark MS, Smith DS (1998) The effects of depression and abnormal illness behaviour on outcome following rehabilitation from stroke. Clin Rehabil 12: 73-80
11. Currier MB, Murray GB, Welch CC (1992) Electroconvulsive therapy for post-stroke depressed geriatric patients. J Neumpsvch Clin Neiimsci 4: 140^t
12. Dahmcn N, Marx J. Hops HC. Tettenborn B, Roder R (1999) Therapy of early post stroke depression with venlafaxine: safety, tolerability and efficacy as determined in an open uncontrolled clinical trial. Letter. Stroke 30(3): 691-2
13. Dam M, Tonin P. De Boni A et al. ( 1996) Effects of fluoxetine and maprotiline on functional recovery in post stroke hémiplégie patients undergoing rehabilitation therapy. Stroke 21: 1211-4
14. Davies B. Burrows G. Poynton C (1975) A comparative study of four depression rating scales. Ausl NZ J Riycltiatir 9: 21
15. Dennis M, O'Rourke S, Slattery J, Staniforth T, Warlow C (1997) Evaluation of a stroke family care worker: results of a randomised controlled trial. Br AfeJ./314: 1071-7
16. Drummond A, Walker M (1996) Generalization of the effects of leisure rehabilitation for stroke patients. Br J Occup Ther 59: 33(M
17. Evcrson SA. Roberts RE, Goldberg DE, Kaplan GA (1998) Depressive symptoms and increased risk of stroke mortality over a 29 vear period. Arch Intern Med 158: 1133-8
18. Folstein M. Ma'iberger R, McHugh P (1977) Mood disorder as a specific complication of stroke. J Neurol Neuw.iurg Pm-hiatry 40: 1018-20
19. Gelder M/Gath D, Mayou R, Cowen P (1996) Oxford Textbook of Psvchiatn: Oxford University Press, Oxford
20. Grade C. Redford B, Chrostowski J. Toussaint L, Blackwell B (1998) Methylphenidate in early post stroke recovery: a double-blind placebo-controlled study. Arch Phvs Med RehahilT)(9): 1047-50
21. Herrmann N. Black SE, Lawrence J, Szekely C, Szalai JP (1998) The Sunnybrook stroke study. Stroke 29: 618-24
22. House A. Dennis M, Molyneux A, Warlow C, Haughton K (1990) Emotionalism after stroke. Br Med J 298: 9911
23. Kotila M. Numminen H. Waltimo O, Kaste M (1998) Depression after stroke; results of the FINNSTROKE study. Stroke 29: 368- 72
24. Lazarus LW, Moberg PJ, Langsley PR, Lingham VR (1994) Methylphenidate and nortriptyline in the treatment of post stroke depression: a retrospective comparison. Arch Phvs Med Rehabil 75: 403-6
25. Lcsher EL, Berryhill JS (1994) Validation of the Geriatric Depression Scale-Short Form among inpatients. J Clin Psvchiatn 50: 256-60
26. Lincoln NB, Flannaghan T, Sutcliffe L. Rother L (1997) Evaluation of cognitive behavioural treatment for depres-sion after stroke: a pilot study. Clin Rehahil 11:114-22
27. Lipsey JR, Pearlson GD, Price TR, Robinson RG, Rao K (1984) Nortriptyline treatment of post stroke depression: A double-blind study. Lancet i: 297-300
28. Masand P, Murray G, Pickett P (1991) Psycho stimulants in post-stroke depression. J Neumpsych Clin Neurosci 3: 23-7
29. Montgomery S, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psvchiatrv 134: 322-89
30. Morris PLP, Raphael B, Robinson RG (1992) Clinical depression is associated with impaired recovery from stroke. MedJAu.it 157: 239-42
31. Murray GB. Shea VM, Conn DK (1986) Electroconvulsive therapy for post-stroke depression. ./ din Psychiatry 41: 258-60
32. O'Rourke S. MacHale S, Signorini D, Dennis M (1998) Detecting psychiatric morbidity after stroke: comparison of the GHQ and the HAD scale. Stroke 29: 980-5
33. Palomaki H, Kaste M, Berg A, Lonnqvist J, Lonnqvist J. Lehtihmes M, Hares J (1999) Prevention of post stroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neural Neitmsurg Psychiatry 66(4): 490-4
34. Pohjasvaara T, Leppavuori A, Siira I, Vataja R, Kaste M, Erkinjuntti T (1998) Frequency and clinical determinants of post stroke depression. Stroke 29: 2311 -7
35. Ramasubbu R, Flint A. Brown G, Awad G, Kennedy S (1998) Diminished serotonin-mediated prolactin responses in non-depressed stroke patients compared with healthy normal subjects. Stroke 29: 1293-8
36. Reding MJ, Orto LA, Winter SW, Fortuna IM, Ponte PD, McDowell FH (1986) Antidepressant therapy after stroke: a double-blind trial. Arch Neural 43: 763-5
37. Robinson RG. Parikh RM, Lipsey JR, Starkstein SE, Price TR (1993) Pathological laughing and crying following stroke - validation of a measurement scale and a double blind treatment study. Am J Psvchiatiy 150: 286-93
38. Schiffer RB, Herndon RM, Rudick RA (1985) Treatment of pathological laughing and weeping with amitryptilline. .V EnglJ Med 314: 1480-2
39. Sloan RL, Brown KW, Pentland B (1992) Fluoxetine as a treatment for emotional lability after brain injury. Brain Injury 6: 315-9
40. Spinhoven PH, Ormal J, Sloekcrs PPA, Kempen GUM, Speckens AEM. Van Hemert AM (1997) A validation study of the Hospital Anxiety and Depression Scale in different groups of Dutch subjects. Psycho/ Med 27: 363-70
41. Stenager EN, Madsen C. Stenagcr E, Boldsen .1 (1998) Suicide in patients with stroke: epidemiological study. Br MeJJ3\6: 1206
42. Sutcliffe L, Lincoln N (1998) The assessment of depression in aphasie stroke patients: the development of the Stroke Aphasie Depression Questionnaire. Clin Rehabil 12: 506-13
43. Wade D (1992) Stroke: rehabilitation and long-term care. Lancet 339: 791-3
44. Wade DT, Legh-Smith J, Hewer RA (1987) Depressed mood after stroke: A community study of its frequency. Br J Psychiatry 151: 200-5
45. Yesavage JA, Brink TL, Rose TL, Lum O, Haung Z, Adey M, Leirer VO (1982-83) Development and validation of a geriatric depression screening scale: a preliminary report. J Pxychiatr Res 17: 37-49
46. Zigmond A, Snaith R (1983) The Hospital Anxiety and Depression Scale. Ada Psychiatr Scand 67: 364-70